GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling - Concepedia

Concepedia

Publication | Closed Access

GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling

57

Citations

40

References

2017

Year

Ying Wang, Song Chen, Xu Zheng, Suting Chen, Wenbing Yao, Xiangdong Gao

Neuropharmacology

Neurodegenerative DiseasesSignal TransductionAlzheimer's DiseaseAberrant Gnt-iii ExpressionG Protein-coupled ReceptorReceptor (Biochemistry)Degenerative PathologyAkt/gsk-3β/β-catenin SignalingGlp-1 Receptor AgonistsNeuroscienceMedicineCell BiologyCell SignalingProtective Mechanisms

References

	Year	Citations

Page 1

Page 1